Literature DB >> 8147304

Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study.

B J Maron1, E E Peterson, M S Maron, J E Peterson.   

Abstract

Although hypertrophic cardiomyopathy (HC) is believed to be a relatively uncommon cardiac disease, the frequency with which it occurs in the general or cardiac population has not been defined. To address this issue, the patient population of a community-based echocardiography laboratory was used to assess the prevalence of HC in 714 consecutively studied outpatients with (or suspected of having) heart disease. The most common cardiac disease identified was mitral valve prolapse (73 patients [10%]), and HC was present in 4 patients (0.5%). Ages were 50 to 69 years. Maximal left ventricular wall thicknessess were 15 to 22 mm (mean 19); only 1 had evidence of obstruction to left ventricular outflow by virtue of marked mitral valve systolic anterior motion. Before echocardiographic study, each of the 4 patients with HC had signs or symptoms of cardiac disease, but the correct diagnosis had not been suspected. Of 11 other patients who were referred for echocardiographic study because of a clinical suspicion of HC, none proved to have this disease. The present study demonstrates that HC is a particularly uncommon disease entity occurring in about 0.5% of an unselected outpatient population referred for echocardiographic study.

Entities:  

Mesh:

Year:  1994        PMID: 8147304     DOI: 10.1016/0002-9149(94)90337-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  Genetics of inherited cardiomyopathy.

Authors:  Daniel Jacoby; William J McKenna
Journal:  Eur Heart J       Date:  2011-08-02       Impact factor: 29.983

2.  Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14).

Authors:  Yigal M Pinto; Arthur Aam Wilde; Ingrid Aw van Rijsingen; Imke Christiaans; Ronald H Lekanne Deprez; Perry M Elliott
Journal:  Eur J Hum Genet       Date:  2011-01-26       Impact factor: 4.246

Review 3.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.

Authors:  W J McKenna; P Spirito; M Desnos; O Dubourg; M Komajda
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

5.  Natural history of hypertrophic cardiomyopathy.

Authors:  P M Elliott
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 6.  Sudden death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  J Cardiovasc Transl Res       Date:  2009-11-13       Impact factor: 4.132

Review 7.  Sudden death in athletes.

Authors:  Vimal Patel; Perry Elliott
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

8.  Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases.

Authors:  Giovanni Cioffi; Eva Gerdts; Dana Cramariuc; Luigi Tarantini; Andrea Di Lenarda; Giovanni Pulignano; Donatella Del Sindaco; Carlo Stefenelli; Giovanni de Simone
Journal:  Exp Clin Cardiol       Date:  2010

9.  Sudden cardiac death athletes: a systematic review.

Authors:  Marcelo Ferreira; Paulo Roberto Santos-Silva; Luiz Carlos de Abreu; Vitor E Valenti; Vanessa Crispim; Caio Imaizumi; Celso Ferreira Filho; Neif Murad; Adriano Meneghini; Andrés R Pérez Riera; Tatiana Dias de Carvalho; Luiz Carlos Marques Vanderlei; Erica E Valenti; José R Cisternas; Oseas F Moura Filho; Celso Ferreira
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-08-03

10.  ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy.

Authors:  I Christiaans; L M Dijksman; E Birnie
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.